Clinical trials resume but still impacted by slow enrollment: GlobalData
There is also a high risk to subjects in a clinical trial who have serious chronic or acute condition that affects their immune…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Trials intelligence
Resumed clinical trials will grow gradually with COVID-19 vaccine rollout: GlobalData
As of February 22, 2021, the number of resumed trials has increased to 955
COVID-19 clinical trial disruption declines but trials continue to suffer from slow recruitment
Trials impacted by enrolment suspension have been on a downward trajectory, while the number of clinical trials with delayed…
COVID-19 disrupted clinical trials with suspended enrollment more likely to resume: GlobalData
The number of trials that have been impacted by slow enrollment has increased by 13.9 per cent
COVID-19 disruption of clinical trials starting to slow: GlobalData
FDA issued guidance recommends methods that could help keep the research going which includes virtual visits, phone interviews,…
COVID-19 continues to disrupt clinical trials
69.9 per cent of disruptions due to the suspension of enrolment, informs a GlobalData study